PeptideStack
5.2kquestions
20kanswers
220users

Is a sampling plan from FGP sufficient basis to skip independent testing?

Asked 9 Feb 2026Modified 38 days agoViewed 5.2k times
4

Numbers first: sampling plan · FGP.

This is a planning question. I know what my options are; I do not know how to weigh them.

What I want is the minimum viable version, which I suspect is smaller than what I would design.

What is the minimum version of this that is still defensible?

coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

749 questions
batch-testing
batch-testing

Testing at the batch or lot level: sampling plans, how many vials from a lot need testing to say anything about the lot, and the difference…

865 questions
harm-reduction
harm-reduction

Reducing avoidable risk where a decision has already been made: independent verification before use, sterility practice, dose arithmetic checked…

445 questions
shareeditfollowflag
DK
askedDr_Sara_Kuusela46k389 Feb 2026

2 Answers

Accepted answer first, then by votes
46

Accepted answer

Before anything else, check that the lot number on the certificate matches the vial in your hand — that traces back to your material and not to some other lot from some other date.

Lot number visibility is the first check, and it is the one most certificates fail — the number is not printed on the vial, or it is on the certificate but the vial is unmarked.

Stated carefully, the laboratory name and accreditation status can be checked in real time against the testing service's own register, and that two-minute check catches substituted certificates.

Published inter-laboratory comparisons of the same material routinely find spreads of half a per cent to a full per cent, which sets realistic expectations.

The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.

shareimprove this answerflag
TA
answered · acceptedtri_gly_ala48k3829 May 2026
Does this hold at lower concentrations, or does adsorption dominate? – kwn_analytical 2 months ago
Worth flagging that this changed in 2025, so older answers on the site are out of date. – v_ramaswamy 4 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
39

Ask whether the certificate answers the question you are actually asking, because the answer is often no.

Writing the lot number on your vial in permanent marker is worth doing because it later proves that the certificate traces to your material.

Batch versus lot is a semantic distinction that determines whether one certificate applies to ten vials or to one, and checking this distinction is worth a minute.

My working rule is that a document without a lot number, a method section and a test date is marketing.

edited 22 Jun 2026 by kirsi_lahtinen — clarified the distinction between purity and content

shareimprove this answerflag
KL
answeredkirsi_lahtinen45k389 Jun 2026
2Adding for future readers: the certificate should carry the lot number, not just a batch code. – lipid_panel_q 8 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.